FairScope Lab
EN 繁中 简中

TMO

Valuation Healthcare · Diagnostics & Research Data as of 2026-03-31

P/E Ratio · Metrics

P/E Ratio

27.76

PEG Ratio

0.37

Dividend Yield

-

Gross Margin

40.67%

Net Margin

15.00%

Revenue CAGR 3Y

0.91%

ROE

12.71%

ROA

5.83%

Buyback Yield

1.06%

Current Ratio

1.53

Magic Earn Yield

3.37%

Altman Z-Score

2.78

Fair Value River

Score

Valuation 52
Profitability 30
Growth 3
Health 53
Yield 18
← Back to Dashboard